37
The
th Annual Meeting of March 19-20, 2016 The Endocrine Society and The Diabetes Association of the R.O.C. (Taiwan)
S1-1
Prof. Leilani B. Mercado-Asis, M.D., Ph.D. Personal Information Nationality: Filipino Position: Professor Department: Internal Medicine Organization: University of Santo Tomas Hospital Email: lanibmasis@gmail.com Educational background & professional experience (in sequence of the latest year) EDUCATIONAL BACKGROUND 2013-2016 Completed graduate Certification on Distance Education/ University of the Philippines 2009-2012 Masteral in Public Health Major in Biostatistics University of the Philippines PROFESSIONAL EXPERIENCE Present Department of Medicine, Hospital of the Infant Jesus October 2012Department of Medical Education and Research October 2013 UST Hospital June 2010Department of Medicine May 2012 UST Faculty of Medicine and Surgery July 2001Section of Endocrinology, Diabetes and July 2010 Metabolism, Department of Medicine UST Hospital Oct 2002 Philippine Orthopedic Hospital Sept 2003
Chairman Research Coordinator Chairman Chief Medical Specialist I
Research Interests 1. PITUITARY 2. ADRENAL 3. DIABETES MELLITUS TYPE2 Publications (5 important publications – latest sequence) 1. Acromegaly with cardiomyopathy,cardiac thrombus and hemorrhagic cerebral infract: A case report of therapeutic dilemma with review of literature. Int J Endocrinol 13(2). (April 2015) 2. Successful Reduction in the size of cystic thyroid nodules with 131iodine therapy Journal of Endocrinology and Metabolism;4:3:12-18 (2014) 3. Removal of dominant adrenal lateralized by glucagon-stimulated adrenal venous sampling alleviates hypertension in bilateral pheochromocytoma. Journal of Life Sciences, ISSN 1934-7391, USA 7:6. (June 2013) 4. Pheochromocytoma: Unmasking the Chameleon.in: Koch CA, Chrousos GP (eds.). Contemporary Endocrinology. Endocrine Hypertension. Springer, New York 2013, pp123-148. (2013) 5. Postprandial peaking and plateauting of trglyceride and VLDL were observed in patients with cardiovascular disease maintained on low fat diet and statin treatment. International Journal of Endocrinology and Metabolism, 10(4):75-81. (2012) 50
